UPDATE: IDEXX Labs (IDXX) Tops Q4 EPS by 62c, Revenues Beat; Offers FY21 EPS/Revenue Guidance Above Consensus
Go back to UPDATE: IDEXX Labs (IDXX) Tops Q4 EPS by 62c, Revenues Beat; Offers FY21 EPS/Revenue Guidance Above Consensus| Idexx Laboratories, Inc. (NASDAQ: IDXX) | Delayed: 550.96 -15.97 (2.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $566.93 | 52 Week High | $117.84 | |||
| Open | $569.14 | 52 Week Low | $63.48 | |||
| Day High | $569.14 | P/E | 158.32 | |||
| Day Low | $549.19 | EPS | $3.48 | |||
| Volume | 530,336 | |||||
